Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Parkinson's Diseasechevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Fabry Disease chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Program Home
    • Access All Programs
    • Specialtieschevron_right
      • chevron_leftTopics
      • Biologics
      • Cancer
      • Cardiology
      • Dermatology
      • Diabetes
      • Hypothyroidism
      • MAC Lung Disease
      • Neurology
      • Primary Care
    • Submit A Question
    close

    John Jefferies, MD

    John Jefferies, MD

    Jay M. Sullivan Endowed Chair in Cardiovascular Medicine
    Chief of Cardiology
    University of Tennessee Health Science Center (UTHSC)
    Co-Director, UT Methodist Institute for Cardiovascular Science
    University of Tennessee Heart Institute
    Memphis, TN


    Related Videos

    What surveillance strategies, in the context of cardiovascular disease, optimize early detection, assessment, and monitoring of patients with suspected or confirmed FD? Video

    What surveillance strategies, in the context of cardiovascular disease, optimize early detection, assessment, and monitoring of patients with suspected or confirmed FD?

    What is the spectrum of cardiovascular manifestations of FD? What is the age of onset? Why is it important that we recognize the cardiovascular clinical phenotypes—arrhythmias, hypertrophic cardiomyopathy, stroke, etc.—of FD? Video

    What is the spectrum of cardiovascular manifestations of FD? What is the age of onset? Why is it important that we recognize the cardiovascular clinical phenotypes—arrhythmias, hypertrophic cardiomyopathy, stroke, etc.—of FD?

    Although GI and dermatologic manifestations tend to dominate the clinical phenotype of FD in childhood, are there cardiovascular manifestations—i.e. arrhythmias—in this subgroup that might point to the disease? Video

    Although GI and dermatologic manifestations tend to dominate the clinical phenotype of FD in childhood, are there cardiovascular manifestations—i.e. arrhythmias—in this subgroup that might point to the disease?

    Given the new therapies—including chaperone therapy with migalastat and ERT—available for FD, why do you believe there should be a “call to action” among the CV community that would heighten awareness of this disease? Video

    Given the new therapies—including chaperone therapy with migalastat and ERT—available for FD, why do you believe there should be a “call to action” among the CV community that would heighten awareness of this disease?

    There is sometimes a preconception that women, who are “carriers” for FD, do not suffer from CV complications and the diagnosis is missed or delayed with adverse consequences. Can you elaborate on this? Video

    There is sometimes a preconception that women, who are “carriers” for FD, do not suffer from CV complications and the diagnosis is missed or delayed with adverse consequences. Can you elaborate on this?

    How does the pathophysiology of Fabry, as a lysosomal disorder, produce the wide range of CV manifestations that should alert physicians to suspect FD as an underlying cause for unexplained symptoms in men and women? Video

    How does the pathophysiology of Fabry, as a lysosomal disorder, produce the wide range of CV manifestations that should alert physicians to suspect FD as an underlying cause for unexplained symptoms in men and women?

    If initial genetic tests or the clinical picture—proteinuria, family history, no evidence of diabetes—suggest FD, what is the next level of diagnostic genetic tests, i.e. mutational testing, that should be performed? Video

    If initial genetic tests or the clinical picture—proteinuria, family history, no evidence of diabetes—suggest FD, what is the next level of diagnostic genetic tests, i.e. mutational testing, that should be performed?

    Are there prospective studies that, in fact, are designed to evaluate the effects of currently approved chaperone- and ERT-based treatments for FD on the progression of CV complications of FD? Video

    Are there prospective studies that, in fact, are designed to evaluate the effects of currently approved chaperone- and ERT-based treatments for FD on the progression of CV complications of FD?

    What are the CV manifestations of FD disease in the adult population and how does the triad of arrhythmias, early MI, and/or cardiomyopathy set into motion diagnostic tests and surveillance strategies to evaluate the presence of FD? Video

    What are the CV manifestations of FD disease in the adult population and how does the triad of arrhythmias, early MI, and/or cardiomyopathy set into motion diagnostic tests and surveillance strategies to evaluate the presence of FD?

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED